7 results
Progression-free Survival  #EBM #Honc #Osimertinib #NSCLC #Survival #NEJM
#Osimertinib #NSCLC ... #Survival #NEJM
The PET better demonstrates the extent of the lymphnode metastases in this patient.
Final diagnosis: small cell
PET #APWindow #AP ... Window #Fullness #SCLC
Here another case. On the PA-film a mass is seen that fills the aortopulmonary window. Final
Lateral #APWindow #AP ... Window #Fullness #SCLC
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer #EBM #Honc #Alectinib #Crizotinib #ALK #ALKPositive #NSCLC
#ALKPositive #NSCLC ... VisualAbstract #NEJM
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
PACIFIC #Durvalumab #NSCLC ... #NEJM
Diagnostic Algorithm for Non–Small-Cell Lung Cancer (NSCLC). The upper portion of the algorithm shows the morphologic
Non–Small-Cell Lung Cancer (NSCLC ... classification of NSCLC ... Honc #Algorithm #NSCLC ... #PDL1 #NEJM
Acromegaly - Diagnosis and Management Summary - GrepMed Handbook 

Clinical Presentation: 
 • Classic Acromegaly: frontal
abdominal carcinoid or SCLC ... • Pituitary MRI